| |
| |
|
| Insider
Information: |
Smith David V |
| Relationship: |
Executive Vice Preside... |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
44,102 |
|
|
Indirect Shares
|
88,570 |
|
|
| Direct
Value |
$135,836 |
|
|
|
Indirect Value
|
$235,596 |
|
|
| Total
Shares |
132,672 |
|
|
| Total
Value |
$371,433 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Achieve Life Sciences Inc |
ACHV |
Director |
2016-05-20 |
9,500 |
2013-05-23 |
0 |
Premium* |
|
|
Codexis Inc |
CDXS |
|
2023-06-13 |
34,602 |
2023-06-13 |
88,570 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
Executive Vice Preside... |
2021-04-16 |
0 |
2018-11-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDXS |
Codexis Inc |
|
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
34,602 |
34,602 |
0 |
- |
|
| CDXS |
Codexis Inc |
|
• • – |
2023-06-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,273 |
0 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
11,273 |
11,273 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2022-06-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,796 |
0 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,796 |
4,796 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2021-06-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,952 |
0 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
66,000 |
138,947 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2021-04-16 |
4 |
D |
$38.00 |
$5,279,986 |
D/D |
(138,947) |
0 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2021-02-24 |
4 |
D |
$25.71 |
$131,378 |
D/D |
(5,110) |
72,947 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2020-12-11 |
4 |
D |
$16.14 |
$185,675 |
D/D |
(11,504) |
78,057 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2020-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
89,561 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2020-11-26 |
4 |
D |
$18.45 |
$127,674 |
D/D |
(6,920) |
67,561 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2020-11-11 |
4 |
D |
$18.00 |
$196,344 |
D/D |
(10,908) |
74,481 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2020-11-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
85,389 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,952 |
8,952 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2020-06-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,947 |
0 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
63,389 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,947 |
4,947 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Vice President & CFO |
• – – |
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,923 |
5,923 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2018-04-03 |
4 |
AS |
$10.37 |
$62,213 |
I/I |
(6,000) |
56,679 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
17,894 |
62,679 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,094 |
44,785 |
0 |
- |
|
| ACHV |
Achieve Life Sciences Inc |
Director |
– • – |
2016-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
9,500 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2016-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,691 |
24,691 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
